îæ€çŽ¢
îæ€çŽ¢
î
Amplify Weight Loss Drug & Treatment ETF
THNRîãŠã©ãããªã¹ãã«è¿œå
25.915USD
+0.173+0.67%
çµå€Â 11-06 16:00ïŒETïŒ
200.00åºæ¥é«
5.14K売買代é
æ¬æ¥
+0.67%
5æ¥é
-0.12%
1ã¶æ
+4.91%
6ã¶æ
+4.71%
幎åæ¥
+2.76%
1幎é
+12.07%
äž»èŠããŒã¿
25.670å§å€
25.742åæ¥çµå€
25.915é«å€
25.660å®å€
200.00åºæ¥é«
5.14K売買代é
1.74åºæ¥é«æ¯ç%
27.94052é±é«å€
23.40052é±å®å€
1.40Kå¹³ååºæ¥é«
1.72%é
åœå©åã
0.413äºæ³å¹Žéé
åœ
Health Careæè³åé
ãããã€ã³ããŒã¹åETF
ãããã¬ãã¬ããžETF
--ã¬ãã¬ããžåç
24.681åºæºäŸ¡é¡ïŒNAVïŒ
USDåºæºäŸ¡é¡é貚
4.42PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
18.88æ ªäŸ¡åççïŒP/EïŒ
Amplify Weight Loss Drug & Treatment ETF ãããã£ãŒã«
äŒæ¥ã³ãŒãTHNR
è³ç£ã¯ã©ã¹Equity
ãã¡ã³ããããŒãžã£ãŒAmplify
èšå®åœUS
çµè²»ç0.59%
èšç«æ¥2024-05-21
ãŠã§ããµã€ãhttps://amplifyetfs.com/thnr/
é£å察象ææ°VettaFi Weight Loss Drug & Treatment Index - Benchmark TR Net
THNR was created on 2024-05-21 by Amplify. The fund's investment portfolio concentrates primarily on health care equity. THNR tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses.
äžäœ10ä¿æéæ
No.販売å称
äŸ¡æ Œ
å€åã
å€åç%
ä¿ææ ªåŒæ°
ãŠã§ã€ã
æ䟡ç·é¡
ãŠã©ãããªã¹ã
Eli Lilly and Co
LLY
1354.000
-10.730
-0.79%
503.00
11.45%
$657.26K
î
Novo Nordisk AS ADR
NVO
40.310
+0.010
+0.02%
12.84K
8.82%
$506.08K
î
Amgen Inc
AMGN
460.420
+0.140
+0.03%
788.00
6.14%
$352.46K
î
4
Roche Holding AG Ordinary Shares new
ROP.SW
--
0.000
--
708.00
5.87%
$337.09K
î
5
Pfizer Inc
PFE
29.390
-0.060
-0.20%
10.90K
5.78%
$331.46K
î
6
AbbVie Inc
ABBV
291.310
+3.070
+1.07%
1.15K
5.71%
$327.68K
î
7
AstraZeneca PLC
AZN.L
--
0.000
--
1.89K
5.68%
$325.81K
î
8
Gilead Sciences Inc
GILD
166.890
-0.680
-0.41%
2.02K
5.54%
$318.15K
î
9
Regeneron Pharmaceuticals Inc
REGN
904.350
+1.450
+0.16%
380.00
5.42%
$311.25K
î
10
Merck & Co Inc
MRK
146.730
-0.210
-0.14%
2.02K
5.20%
$298.16K
î
Amplify Weight Loss Drug & Treatment ETF ãã¯ãã«ã«åæ
ãã¯ãã«ã«ææš
äžç«
èŠçŽ
è²·ã
移åå¹³å
匷åè²·ãæšå¥š
Amplify Weight Loss Drug & Treatment ETF ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
人æ°éæ
î
51290.600
-208.500Â (-0.41%)
26964.500
+329.300Â (+1.24%)
7380.000
+23.100Â (+0.31%)
12797.000
-1.000Â (-0.01%)
58142.000
+876.000Â (+1.53%)
6140.600
-37.200Â (-0.60%)
89.857
-0.176Â (-0.20%)
342.370
-1.800Â (-0.52%)
186.640
+5.040Â (+2.78%)
4065.670
-33.020Â (-0.81%)
ãããã質å
Amplify Weight Loss Drug & Treatment ETFïŒTHNRïŒã®çŸåšã®äŸ¡æ Œã¯ãããã§ããïŒ
îAmplify Weight Loss Drug & Treatment ETFïŒTHNRïŒã®çŸåšäŸ¡æ Œã¯25.91ã§ããåžå ŽããŒã¿ã«ã¯é
延ãçããå ŽåããããããããŒãžäžã«è¡šç€ºãããŠããæŽæ°æ¥æããåç
§ãã ããã
Amplify Weight Loss Drug & Treatment ETFã®52é±é«å€ã¯ãããã§ããïŒ
îAmplify Weight Loss Drug & Treatment ETFã®52é±é«å€ã¯27.94ã§ããææ°ããŒã¿ã«ã€ããŠã¯ãããŒãžã«è¡šç€ºãããŠããæŽæ°æ¥æãã確èªãã ããã
Amplify Weight Loss Drug & Treatment ETFã®52é±å®å€ã¯ãããã§ããïŒ
îAmplify Weight Loss Drug & Treatment ETFã®52é±å®å€ã¯23.40ã§ããææ°ããŒã¿ã«ã€ããŠã¯ãããŒãžã«è¡šç€ºãããŠããæŽæ°æ¥æãã確èªãã ããã
Amplify Weight Loss Drug & Treatment ETFã®NAVïŒçŽè³ç£äŸ¡å€ïŒã¯ãããã§ããïŒ
îæ¬æ¥ã®Amplify Weight Loss Drug & Treatment ETFã®NAVã¯24.68ã§ããNAVã¯ãã¡ã³ãã®ç·è³ç£ããè² åµãå·®ãåŒããçŽè³ç£ãè¡šãã1å£ãããã®æ¬è³ªç䟡å€ã瀺ãææšãšãªããŸãã
Amplify Weight Loss Drug & Treatment ETFïŒTHNRïŒã®ããã©ãŒãã³ã¹ã¯ã©ãã§ããïŒ
îAmplify Weight Loss Drug & Treatment ETFïŒTHNRïŒã®å£²è²·ä»£éã¯5.14Kã§ããéå»1ãæéã®äŸ¡æ Œå€åçã¯6.09%ã§ãéå»1幎éã®ãªã¿ãŒã³ã¯10.84%ã§ãã詳现ã«ã€ããŠã¯Amplify Weight Loss Drug & Treatment ETFã®äŸ¡æ Œãã£ãŒããã芧ãã ããã
Amplify Weight Loss Drug & Treatment ETFïŒTHNRïŒãžã®æè³ã¯å®å šã§ããïŒ
îå®å
šã«ãªã¹ã¯ã®ãªãæè³ã¯ååšããŸãããAmplify Weight Loss Drug & Treatment ETFïŒTHNRïŒã®ãªã¹ã¯ã¬ãã«ã¯ããã®åè³ç£ãæŠç¥ãæµåæ§ãææ°æãããã³åžå Žç°å¢ã«ãã£ãŠç°ãªããŸããåæ£æè³ã«ããæœåšçãªæ倱ã軜æžã§ããå ŽåããããŸããããªã¹ã¯ãå®å
šã«æé€ããããšã¯ã§ãããéå»ã®å®çžŸã¯å°æ¥ã®ææãä¿èšŒãããã®ã§ã¯ãããŸãããæè³ãè¡ãåã«ãåœè©²ãã¡ã³ãããèªèº«ã®ç®æšããªã¹ã¯èš±å®¹åºŠã«åèŽããŠãããããæ€èšãã ãããæ¬å
容ã¯æè³å©èšãæ§æãããã®ã§ã¯ãããŸããã